8-K
filed December 17, 2024, 6:59 PM ET
ticker RXRX
CIK 0001601830
other material
confidence high
sentiment neutral
materiality 0.20
Recursion registers 3.5M shares for resale by Tempus Labs as license fee payment
RECURSION PHARMACEUTICALS, INC.
- Recursion filed prospectus supplement to register 3,498,393 shares for resale by Tempus Labs.
- Shares were issued to Tempus as payment for 2024 annual license fee under Master Agreement dated Nov 2023.
- Offering made under exemption from registration; no new issuance or capital raise for Recursion.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001601830-24-000245
- form_type
- 8-K
- ticker
- RXRX
- cik
- 0001601830
- company_name
- RECURSION PHARMACEUTICALS, INC.
- filed_at
- 2024-12-17T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:08.937232+00:00
- generated_at
- 2026-05-29T02:25:17.302696+00:00
- sec_items
- ["8.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.2
- calibrated_materiality_score
- 0.2
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001601830-24-000245
- json_url
- https://secwatch.observer/filing/0001601830-24-000245.json
- markdown_url
- https://secwatch.observer/filing/0001601830-24-000245.md
- text_url
- https://secwatch.observer/filing/0001601830-24-000245.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000245/0001601830-24-000245-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1601830/000160183024000245/rxrx-20241217.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IMAQ
International Media Acquisition extends business combination deadline to July 2, 2026
International Media Acquisition Corp.
June 1, 2026, 4:45 PM ET
other_material
Items 8.01, 9.01
same SEC item: 8.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MPT
MPT shareholders elect all directors, approve say-on-pay and equity plan with notable opposition
MEDICAL PROPERTIES TRUST INC
June 1, 2026, 4:55 PM ET
other_material
Items 5.07, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LXU
LSB Industries accelerates Pryor, OK turnaround start to May 28, 2026
LSB INDUSTRIES, INC.
June 1, 2026, 4:35 PM ET
other_material
Items 8.01
same SEC item: 8.01
same event type: other_material
similar materiality
Filing page
SEC filing
STRR
Star Equity furnishes investor presentation covering operations as of March 31, 2026
Star Equity Holdings, Inc.
June 1, 2026, 4:34 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
SEVN
Seven Hills Realty Trust posts June 2026 investor presentation to website
Seven Hills Realty Trust
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
WEC
WEC Energy Group files investor presentation for June 2026 meetings; content not available
WEC ENERGY GROUP, INC.
June 1, 2026, 4:18 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
EPRT
Essential Properties releases June 2026 investor presentation; no new material data disclosed
ESSENTIAL PROPERTIES REALTY TRUST, INC.
June 1, 2026, 4:17 PM ET
other_material
Items 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LODE
Comstock holds AGM; all director nominees elected, auditor and equity plan approved
Comstock Inc.
June 1, 2026, 4:15 PM ET
other_material
Items 5.07, 7.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.